Illumina competitors

Illumina Competitors include Synthetic Genomics, Nightstar Therapeutics, Aevi Genomic Medicine and Ultragenyx Pharmaceutical.
Add company...
Illumina
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Synthetic Genomics
Synthetic Genomics
Synthetic Genomics is a synthetic biology company that develops and commercializes genomic-driven technologies for various industries.
Nightstar Therapeutics
Nightstar Therapeutics
Nightstar Therapeutics is a clinical-stage gene therapy company, focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.
Aevi Genomic Medicine
Aevi Genomic Medicine
Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Founding Date
Founding Date
1998
Founding Date
2005
Founding Date
2013
Founding Date
2000
Founding Date
2010
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Locations
La Jolla, US HQ
Locations
London, GB HQ
Lexington, US
Locations
Wayne, US HQ
San Francisco, US
Locations
Novato, US HQ
Employees
Employees
6,200
Employees
1805% decrease
Employees
2717% increase
Employees
24
Employees
376
Valuation ($)
Valuation ($)
49.1 b
Valuation ($)
N/A
Valuation ($)
419.6 m
Valuation ($)
71.2 m
Valuation ($)
2.6 b
Twitter followers
Twitter followers
57 k
Twitter followers
2.8 k
Twitter followers
115
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$2.8b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$2.6m (FY, 2017)
Cost of goods
Cost of goods
$926m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$1k (FY, 2017)
Gross profit
Gross profit
$1.8b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$2.6m (FY, 2017)
Net income
Net income
$678m (FY, 2017)
Net income
N/A
Net income
($12.2m) (FY, 2016)
Net income
($34.7m) (FY, 2017)
Net income
($302.1m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 40m
Total funding raised
$ 99.6m
Total funding raised
$ 7m
Total funding raised
$ 200.1m
For sources of this data, please see the company profileDownload Excel

View company profiles

Synthetic Genomics
HQ
La Jolla, US
Employees
180↓ 5% decrease

Synthetic Genomics is a synthetic biology company that develops and commercializes genomic-driven technologies for various industries.

View company
Nightstar Therapeutics
HQ
London, GB
Employees
27↑ 17% increase

Nightstar Therapeutics is a clinical-stage gene therapy company, focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.

View company
Aevi Genomic Medicine
HQ
Wayne, US
Employees
24

Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.

View company
Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
376

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

View company